Maryland State Retirement & Pension System’s Iovance Biotherapeutics IOVA Stock Holding History

Maryland State Retirement & Pension System’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,000	Closed	-$183K	–	1510
2022 Q1	$183K	Hold	11,000	–	–	﹤0.01%	1475
2021 Q4	$210K	Hold	11,000	–	–	0.01%	1475
2021 Q3	$266K	Hold	11,000	–	–	0.01%	1413
2021 Q2	$282K	Hold	11,000	–	–	0.01%	893
2021 Q1	$348K	Buy	+11,000	New	+$456K	0.01%	857

Other funds holding IOVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Maryland State Retirement & Pension System's IOVA Position: Q2 2022 in Review

Maryland State Retirement & Pension System sold out of Iovance Biotherapeutics (IOVA) in Q2 2022, closing a stake of 11,000 shares — an estimated $183K sold.

Maryland State Retirement & Pension System first reported a position in IOVA in Q1 2021 and held it in 5 quarters. The position peaked at $348K in Q1 2021. 237 funds tracked by Wall St. Rank hold IOVA as of Q2 2022.

Maryland State Retirement & Pension System reported no remaining Iovance Biotherapeutics position as of Q2 2022 after selling out during the quarter.
Maryland State Retirement & Pension System sold 11,000 Iovance Biotherapeutics shares in Q2 2022, an estimated $183K.
Maryland State Retirement & Pension System first reported a position in Iovance Biotherapeutics in Q1 2021 and held it in 5 quarters.
Maryland State Retirement & Pension System's Iovance Biotherapeutics position peaked at $348K in Q1 2021.
237 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2022.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2022, filed 1 Aug 2022.